MARATTO

article · Biochemical Pharmacology

Unveiling the protective potential of mirabegron against thioacetamide-induced hepatic encephalopathy in rats: Insights into cAMP/PPAR-γ/p-ERK1/2/p S536 NF-κB p 65 and p-CREB/BDNF/TrkB in parallel with oxidative and apoptotic trajectories

In plain language

No abstract is available for this record, so no summary has been generated.

Research topics

  • Drug-Induced Hepatotoxicity and Protection
  • Liver Disease and Transplantation
  • Drug Transport and Resistance Mechanisms

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1016/j.bcp.2024.116504

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.